Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MacKay Group Chairman James MacKay On Pursuing A “Starbucks” Model For Diagnostics In China: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Armed with a stable of non-invasive diagnostic technologies, the MacKay Group plans to capitalize on the growing need across Asia for inexpensive diagnostic equipment. Last month, the company acquired new cervical cancer diagnostic products through its Biofield unit to complement its own breast cancer diagnostic products, which sell for less than $20,000 (PharmAsia News, Feb. 12, 2009). MacKay Group Chairman James MacKay spoke to PharmAsia News' Hong Kong bureau to outline his vision for a "Starbucks approach" to health care, one in which cancer screenings go alongside facials and manicures at a nearby beauty salon. That reality, he says, is just around the corner.
Advertisement

Related Content

More Investment In China’s Health Care System Unveiled During NPC;  Is It Time To Ask Who Will Benefit First And Most?
Diagnostic Firm Biofield Looks To Broaden Scope in China and India
Diagnostic Firm Biofield Looks To Broaden Scope in China and India
Advertisement
UsernamePublicRestriction

Register

SC071082

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel